Literature DB >> 14755634

The highly selective 5-hydroxytryptamine (5-HT)2A receptor antagonist, EMD 281014, significantly increases swimming and decreases immobility in male congenital learned helpless rats in the forced swim test.

Jignesh G Patel1, Gerd D Bartoszyk, Emmeline Edwards, Charles R Ashby.   

Abstract

We examined the effect of the highly selective 5-hydroxytryptamine (5-HT)(2A) receptor antagonist 7-[4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-1-carbonyl]-1H-indole-3-carbonitrile HCl (EMD 281014) in congenital learned helpless male rats in the forced swim test. The administration of EMD-281014 (0.3-30 mg/kg i.p.) to congenital learned helpless rats dose-dependently and significantly (at 10 and 30 mg/kg) decreased immobility and increased swimming compared to vehicle-treated animals. Thus, EMD 281014 produces effects in the forced swim test resembling those of antidepressants. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755634     DOI: 10.1002/syn.10308

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  13 in total

1.  Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.

Authors:  Alvin V Terry; Jerry J Buccafusco; Gerd D Bartoszyk
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

2.  Metabolic mapping of the effects of the antidepressant fluoxetine on the brains of congenitally helpless rats.

Authors:  Jason Shumake; Rene A Colorado; Douglas W Barrett; F Gonzalez-Lima
Journal:  Brain Res       Date:  2010-05-12       Impact factor: 3.252

3.  5-HT₂A receptor inactivation potentiates the acute antidepressant-like activity of escitalopram: involvement of the noradrenergic system.

Authors:  G Quesseveur; C Repérant; D J David; A M Gardier; C Sanchez; B P Guiard
Journal:  Exp Brain Res       Date:  2013-02-15       Impact factor: 1.972

4.  Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models.

Authors:  Shao-wen Tian; Moshe Laudon; Li Han; Jun Gao; Fu-lian Huang; Yu-feng Yang; Hai-feng Deng
Journal:  Acta Pharmacol Sin       Date:  2010-06-28       Impact factor: 6.150

5.  Subchronic treatment with fluoxetine and ketanserin increases hippocampal brain-derived neurotrophic factor, β-catenin and antidepressant-like effects.

Authors:  F Pilar-Cuéllar; R Vidal; A Pazos
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 6.  The role of serotonin receptor subtypes in treating depression: a review of animal studies.

Authors:  Gregory V Carr; Irwin Lucki
Journal:  Psychopharmacology (Berl)       Date:  2010-11-24       Impact factor: 4.530

7.  Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety- and depressant-like effects in cocaine- or MDPV-abstinent rats.

Authors:  Helene L Philogene-Khalid; Callum Hicks; Allen B Reitz; Lee-Yuan Liu-Chen; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2017-06-13       Impact factor: 4.492

8.  Astroglial Serotonin Receptors as the Central Target of Classic Antidepressants.

Authors:  Alexei Verkhratsky; Vladimir Parpura; Caterina Scuderi; Baoman Li
Journal:  Adv Neurobiol       Date:  2021

9.  Synaptic abnormalities in the infralimbic cortex of a model of congenital depression.

Authors:  Ronald R Seese; Lulu Y Chen; Conor D Cox; Daniela Schulz; Alex H Babayan; William E Bunney; Fritz A Henn; Christine M Gall; Gary Lynch
Journal:  J Neurosci       Date:  2013-08-14       Impact factor: 6.167

10.  Assessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout models.

Authors:  R Rajkumar; R Mahesh
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.